ZLAB
Zai Lab Ltd
Key Financials
Operating Income
$-229434000
↑ 18.7%
Revenue
$460.2M
↑ 15.3%
Net Income
$-175537000
↑ 31.7%
Total Assets
$1.2B
↓ 1.1%
EPS (Diluted)
$-0.16
↑ 38.5%
Cash & Equivalents
$679.6M
↑ 51.1%
Total Liabilities
$456.9M
↑ 32.5%
Shareholders' Equity
$715.5M
↓ 14.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 8/18/2026 | View on SEC |
| 4 | 8/13/2026 | View on SEC |
| 4 | 8/13/2026 | View on SEC |
| 144 | 8/12/2026 | View on SEC |
| 144 | 8/11/2026 | View on SEC |
| 10-Q | 8/6/2026 | View on SEC |
| 8-K | 8/6/2026 | View on SEC |
| 4 | 7/6/2026 | View on SEC |
| 4 | 7/6/2026 | View on SEC |
| 4 | 7/1/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ZLAB |
| Company Name | Zai Lab Ltd |
| CIK | 1704292 |
| Sector | Pharmaceutical Preparations |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | E9 |
| Phone | 862161632588 |